BioLife Solutions, Inc. (BLFS)
23.09
-0.14
(-0.60%)
USD |
NASDAQ |
Feb 20, 16:00
23.11
+0.02
(+0.09%)
After-Hours: 20:00
BioLife Solutions Research and Development Expense (Quarterly) : 2.709M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 18.68M |
| Artivion, Inc. | 9.122M |
| DexCom, Inc. | 148.20M |
| Edwards Lifesciences Corp. | 267.70M |
| Nutriband, Inc. | 0.4571M |